Guidelines on the benefit-risk assessment of the presence of phthalates in certain medical devices covering phthalates which are carcinogenic, mutagenic, toxic to reproduction (CMR) or have endocrine-disrupting (ED) properties
de Jong, Wim H., Scheer,, Bertollini, Roberto, Borges, Teresa, De Jong, Wim, de Voogt, Pim, Duarte-Davidson, Raquel, Hoet, Peter, Ion, Rodica Mariana, Kraetke, Renate, Panagiotakos, Demosthenes, ProyJournal:
Regulatory Toxicology and Pharmacology
DOI:
10.1016/j.yrtph.2019.104546
Date:
December, 2019
File:
PDF, 529 KB
2019
File converter
More search results
More benefits 
